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Abstract
Background: Practice accreditation is widely used to assess and improve quality of healthcare providers. Little is
known about its effectiveness, particularly in primary care. In this study we examined the effect of accreditation on
quality of care regarding diabetes, chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD).
Methods: A comparative observational study with two cohorts was performed. We included 138 Dutch family
practices that participated in the national accreditation program for primary care. A first cohort of 69 practices was
measured at start and completion of a 3-year accreditation program. A second cohort of 69 practices was included
and measured simultaneously with the final measurement of the first cohort. In separate multilevel regression
analyses, we compared both within-group changes in the first cohort and between-groups differences at follow-up
(first cohort) and start (second cohort). Outcome measures consisted of 24 systematically developed indicators of
quality of care in targeted chronic diseases.
Results: In the within-group comparison, we found improvements on 6 indicators related to diabetes (feet examination,
cholesterol measurement, lipid lowering medication prescription) and COPD (spirometry performance, stop smoking
advice). In the between-groups comparison we found that first cohort practices performed better on 4 indicators related
to diabetes (cholesterol outcome) and CVD (blood pressure outcome, smoke status registration, glucose measurement).
Conclusions: Improvements of the quality of primary care for patients with chronic diseases were found, but few could
be attributed to the accreditation program. Further development of accreditation is needed to enhance its effectiveness
on chronic disease management.
Keywords: Accreditation, Chronic disease, Primary health care, Quality improvement
Background
A range of strategies has been developed to assess and im-
prove healthcare for patients with chronic diseases [1]. A
widely used strategy is accreditation of healthcare pro-
viders [2,3]. Accreditation affects the institution or practice
and is offered more or less voluntary, while certification
focuses on a specific norm that should be reached by indi-
viduals or particular services [4,5]. A key element of ac-
creditation is audit and feedback. A Cochrane review
suggested that an audit and feedback system has a small
positive effect on quality of care overall [6], but the added
value of accreditation was not considered. Greenfield
et al. [7] suggested in their systematic review that ac-
creditation can promote change, for example through
the opportunity to reflect on organizational perform-
ance, and that it has an effect on professional develop-
ment. However, they reported inconsistent findings
regarding quantifiable effects of accreditation on mea-
sures of clinical processes and outcomes. Few rigorous
evaluations of effectiveness of accreditation are available,
particularly in primary care [8-10]. O’Beirne et al. [10]
performed a review of peer-reviewed and grey literature
regarding accreditation in primary care. They found indi-
cations that accreditation may improve both organization
and outcomes of care, but conclude that more research is
needed. Szecsenyi et al. [11] examined an accreditation
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program that focuses on practice management; they
found improvements on several quality and safety mea-
sures regarding complaint management, analysis of
critical incidents and quality development. Given the
shortage of controlled evaluations, more research on
the effects of well-defined accreditation programs is
required.
In this study we assessed an accreditation program
for primary care practices [12,13], set up by the Dutch
college of General Practitioners in 2005. This program
strongly focuses on the educational value of audit and
feedback and participation is voluntary. However, part
of the program does require meeting specific norms,
for example on hygiene, first aid equipment and ac-
cessibility. The program addresses clinical care as well
as practice management. The clinical care section
consists mainly of three chronic care conditions: dia-
betes mellitus, chronic obstructive pulmonary disease
(COPD) and cardiovascular disease (CVD).
In the same period, health insurers developed bun-
dled payment schemes, with an initial focus on dia-
betes (approximate start in 2008), and in later years
also on COPD (since 2009) and CVD (since 2011)
[14,15]. Bundled payment is suggested as a method to
control costs while providing more patient centered,
higher quality care [16]. An international review of
different types of bundled payment [17] suggests that
there is weak but consistent evidence for a positive ef-
fect of bundled payment on healthcare costs, with no
tangible impact on quality of care. Studies on the ef-
fect of bundled payment in the Netherlands show that
it improved organization and management of care
[18,19] and potentially also the outcomes of diabetes
care [20]. Nevertheless, a Cochrane review concluded
that there is insufficient evidence to draw firm conclu-
sions on the effectiveness of different these types of
reimbursement schemes [21].
This study is focused on effects of the Dutch prac-
tice accreditation program in the context of a health-
care system, in which provider reimbursement of
chronic illness care was improved simultaniously. In
the Netherlands, approximately 80% of diabetes pa-
tients has the family physician (FP) as the principal
caregiver. This percentage is slightly lower for COPD
and CVD patients (50-65%). Generally, patients with
the FP as main care provider tend to be stable, al-
though not necessarily well controlled. The study
aimed to determine whether participation in the ac-
creditation program led to improvements in quality of
care regarding diabetes, chronic obstructive pulmon-
ary disease (COPD) and cardiovascular disease (CVD).
We also aimed to assess whether the improved per-
formance was different from the performance during
pre-assessment of a second group of participants.
Methods
Study design
We performed a comparative observational study with
two cohorts of primary care practices. A first cohort of
practices was followed throughout the 3-year program
with extended measurements at start and after three
years. A second cohort was measured at their start of
the accreditation program, during the same period of
the post-assessment in the first cohort. Data collected at
the start of the practice accreditation process portrayed
practice performance prior to the accreditation process:
data were collected retrospectively over a one year
period prior to the start. We evaluated the effect of prac-
tice accreditation in a design with two separate compari-
sons. In the first comparison we assessed improvements
over time within the first cohort. In the second compari-
son we assessed differences between the first and second
cohort by comparing the follow-up measurement of the
first cohort with the start measurement of the second
cohort. Since both of these groups collected data in the
same period, this comparison could offer additional in-
formation on effects of accreditation (3 years experience
versus start of accreditation). The ethics committee of
the Radboud university medical center provided a waiver
for the study.
Study population
Practices included in the study were Dutch primary care
practices that participated in the accreditation program
of the Dutch College of General Practitioners between
2006 and 2011. We included a group of 69 practices in
the first cohort that joined the accreditation program be-
fore 2009 and had collected follow-up data. Start mea-
surements took place between 2006 and 2008; follow-up
measurements of this cohort took place between 2009
and 2011. The average time period between data collec-
tion in the first cohort was four years and two months,
with a minimal interval of 3 years and 2 months.
The second cohort consisted of primary care practices
that had their start measurement between 2009 and
2011. We used a matched design to select an equally
large sample of 69 practices (see Figure 1). Matching
was based on availability of data, practice location (de-
gree of urbanization), visitation date, practice type, and
practice size.
Practice accreditation
Practices have been invited to participate voluntarily in
the Dutch practice accreditation program since 2005.
The preparatory phase of the program consisted of data
collection regarding practice management and patient
care. The measurement instruments used were previ-
ously validated questionnaires such as the ‘VIP’, a visit-
ation instrument for practice organization [22] and the
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‘Europep’ [23] for patient experiences with care. The
clinical performance indicators were derived from the
national guidelines valid at the time of measurement
[24]. These indicators were measured with the use of pa-
tient information that was extracted from electronic
medical records; the family physician (FP) or nurse ex-
tracted the information either automatically or manually
with a standardized extraction form. After data submis-
sion via an online system, the practice received a report
that included information on their own performance
and the performance of other practices as a benchmark.
This information could be used to identify which areas
needed improvement. The FPs wrote improvement plans
with a plan-do-study-act cycle. The first audit was car-
ried out after the approval of these plans to confirm ad-
equate participation and to grant accreditation. After
this audit a three-year accreditation cycle started. At the
end of each year the practice staff evaluated whether the
objectives of improvement programs were met and
wrote new improvement plans for the following year.
The prolongation of accreditation depended on this
process; accreditation was not based on the actual qual-
ity of care itself, but rather on the quality of the im-
provement initiatives according to a structured program.
Performance indicators
The primary care practice maintains comprehensive pa-
tient records, which includes information on all contacts
and procedures in primary care, hospital, and several
other care providers. For this study, we excluded all pa-
tients of which the FP was not the main care provider.
All information used in this study was collected as part
of the accreditation program. The prevalence of diabetes
and COPD was defined as the number of patients with
the condition divided by the total number of patients in
the practice. Indicators of both process of care and inter-
mediate outcomes were included regarding patients with
diabetes, COPD and CVD (Table 1). The data that were
collected before 2009 on CVD related to a broader range
of patients; patients with high risk for CVD were also in-
cluded. Since this made it impossible to compare data
over time we only included data after 2009, that relate to
patients with known CVD. During our research period
several target levels as described in the guidelines shifted
for diabetes (relating to indicators 2 and 3) and for CVD
(indicator 2). We calculated the percentage of patients
with a level below target level according to the target
level that was valid at the time of measurement. Data on
practice characteristics were collected through the use of
online questionnaires which were also part of the prac-
tice accreditation program.
Analyses
Descriptive statistics were used to describe the practice
population and gain insight in the performance scores.
For each of the three conditions we calculated a mean
score for several process indicators. Some indicators
could not be included in the mean scores due to low in-
ternal consistency with other indicators or use of sub-
samples: diabetes indicator 5, COPD indicator 3 and
CVD indicators 4, 5 and 6 (Table 1).
In order to examine whether chronic care manage-
ment improved after the three year cycle of the accredit-
ation program, we compared the start and follow-up
scores of the first cohort in a within-subject design. We
performed separate multilevel regression analyses for
Practices that registered to start with the
Dutch accreditation program between 
2009 and 2011
n = 802
Practices that collected data on diabetes, 
COPD and CVD
n= 440
Practices that matched the first cohort 
ranked according to best match
n= 128
Second confirmation of no participation 
before 2009; practices that matched best 
to first cohort
n = 69
Exclusion n = 362
no data on diabetes,
COPD and / or CVD 
Exclusion n = 312
no match with practices 
in first cohort
Exclusion n = 59
less optimal match with 
practices in first cohort
Figure 1 Selection of practices in the second cohort.
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each indicator. We accounted for repeated measures per
practice and included predictors reflecting practice size,
practice type and practice location.
Practices in the first cohort were compared to prac-
tices in the second cohort on follow-up and baseline
scores respectively, in a separate regression analysis. The
comparison was corrected for the match criteria practice
size, practice type and practice location in each model.
All analyses were performed with SPSS version 20 [25].
Results
Practice characteristics
Table 2 shows the percentages and means of different
practice characteristics in each group. There was a slight
underrepresentation of practices that were part of a
health center in the second cohort compared to the first
cohort: 8 (12%) versus 11 (16%) practices. They were
slightly more often located in an urban area (25 (36%)
versus 23 (33%) practices). The mean number of patients
in the practice increased in time; mean practice size was
similar in the two cohorts.
Within-group comparison
The first two columns in Table 3 report on scores at
start and follow-up of practices in the first cohort. The
recorded prevalence of diabetes increased from 40 to 50
per 1000 patients. The recorded prevalence of COPD
also increased, from 17 to 22 per 1000 patient. The
prevalence of CVD/CVRM was not measured.
Table 3 also reports results from the multilevel regres-
sion analyses. Regarding diabetes we found that practices
had improved on three performance indicators. Practice
scores had higher percentages of patients with a re-
corded cholesterol measurement (p 0.04), feet examin-
ation (p 0.03) and prescription of lipid lowering
medication (p 0.009). The percentage of patients with a
blood pressure below target level was marginally lower
at follow up (p 0.08). Practices in the first cohort had
Table 1 Description of performance scores
Topic No. Description
Diabetes
Outcome 1 Percentage of patients with an HbA1c level within target level (<53 mmol/mol)
2 Percentage of patients with a blood pressure within target level (2006-2008: <150/80 mm Hg, 2009-2011: systolic <140 mm Hg)
3 Percentage of patients with a total cholesterol level within target level (2006-2008: <5.0 mmol/l, 2009-2011: <4.5 mmol/l)
Process 4 Calculated mean process score based on the following 6 performance measures:
4a Percentage of patients with at least one HbA1c measurement in the past 12 months
4b Percentage of patients with at least one blood pressure measurement in the past 12 months
4c Percentage of patients with at least one cholesterol measurement in the past 12 months
4d Percentage of patients with a creatinine clearance calculation in the past 12 months
4e Percentage of patients with a retinal examination in the past 24 months
4f Percentage of patients with a feet examination in the past 12 months
5 Percentage of patients with a current prescription of lipid lowering medication
Chronic obstructive pulmonary disease (COPD)
Outcome 1 Percentage of patients that smoke
Process 2 Calculated mean process score based on the following 2 performance measures:
2a Percentage of patients with a known smoke status
2b Percentage of patients with a spirometry in the past 12 months
3 Percentage of patients that smoke with a stop smoking advice
Cardiovascular disease (CVD)
Outcome 1 Percentage of patients that smoke
2 Percentage of patients with a blood pressure level within target level (2006-2008: <160/90 mm Hg, 2009-2011: systolic <140 mm Hg)
Process 3 Calculated mean process score based on the following 2 performance measures:
3a Percentage of patients with a known smoke status
3b Percentage of patients with at least one blood pressure measurement in the past 12 months
4 Percentage of patients that smoke with a stop smoking advice
5 Percentage of patients with a glucose measurement in the past 12 months
6 Percentage of patients with a current prescription of anticoagulants
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improved on three COPD process indicators. There was
an increase in the percentage of patients with a recorded
spirometry measurement (p 0.000), which was the sole
contributor to the effect on the mean process score
(p 0.01). We also found a large improvement in the per-
centage of patients who smoke that received an advice
to stop smoking (p 0.002).
Between-groups comparison
The figures for the between-groups comparison are re-
ported in the columns on the right side of Table 3. No
differences were found in the recorded prevalence of
diabetes and COPD.
Diabetes patients in the second cohort less often had a
total cholesterol value within target level compared to
the patients in the first cohort (p 0.02). No other differ-
ences were found between the two cohorts regarding
diabetes. We did not find any differences on COPD per-
formance indicators. Practices in the first cohort pro-
vided higher quality of care than the second cohort on
three CVD performance indicators. A higher percentage
of patients had a blood pressure within target level
(p 0.03). Furthermore, the number of patients with re-
corded smoke status (p 0.02) and glucose values (p 0.02)
had increased.
Discussion
Summary
Improvements were found regarding cholesterol meas-
urement, feet examination and the prescription of lipid
lowering medication (diabetes), spirometry performance
and the provision of a stop smoking advice (COPD). As
the follow-up measurement scores on these performance
measures were similar to the baseline scores in the sec-
ond cohort, it remains uncertain whether the effect can
be attributed to the accreditation program. Compared to
the second cohort of newly starting practices, the prac-
tices in the first cohort performed better regarding
achievement of a target cholesterol level (diabetes) and
blood pressure level (CVD) and the registration of
smoke status and measurement of glucose levels (CVD).
These differences could provide evidence for the added
value of the accreditation program.
Explanation of findings
Our results are consistent with previous studies that
show that there might be an effect of accreditation on
quality of care processes and outcomes, although effects
are not always consistent [6,7,10]. Furthermore, we
mainly found improvements over time on those mea-
sures that had a lower score at baseline, which is consist-
ent with findings from a systematic review on quality
improvement strategies [26]. Several scores, especially
regarding diabetes, were already quite high, which might
be a reflection of the general amount of attention to-
wards diabetes care improvement, but it can also be re-
lated to the relatively large numbers of practices that
provide vocational training in our study population,
which is associated with better quality of care [27]. In
the Netherlands, approximately 30% of all practices have
at least one family physician that provides training. In our
population the percentage of practices with training was
higher in both cohorts: 61% (42 of 69 practices) and 70%
(48 of 69) in the first and second cohort respectively.
In the Dutch accreditation program, the practice is
accredited if it is actively involved in quality improve-
ment through use of improvement plans and can achieve
improvements over time. An advantage of this approach
is that the program is more attractive for health profes-
sionals; they take ownership of the improvement plans
that are tailored to the individual practices. Like other
accreditation programs, it uses audit and feedback as a
Table 2 Practice characteristics
Practices in first cohort Practices in second cohort
Practice characteristic 2006-2008 2009-2011 2009-2011
N % N % N %
Practice type
Single handed 17 25% 18 26% 19 27%
Health center 10 14% 11 16% 8 12%
Other 42 61% 40 58% 42 61%
Practice location1
Urban 23 33% 23 33% 25 36%
Semi-urban 34 49% 34 49% 33 48%
Rural 12 18% 12 18% 11 16%
Average number of patients per practice 4629 4808 4830
1A region was defined as urban when the number of addresses per km2 exceeded 1500. Semi-urban regions had between 500 and 1500 addresses per km2, rural
regions had less than 500 addresses per km2.
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central mechanism, embedded in a continuous quality
improvement process that aims to enhance a culture
that fosters quality and safety of healthcare [4,28]. The
fact that we did not find stronger evidence for an added
value of the accreditation program may be partially ex-
plained by other developments in the primary care field
Table 3 Within-practice comparison of first and second measurement of practices in first cohort and between practice
comparison of first and second cohort in 2009-2011
Indicators1 1st cohort Within-group comparison of
1st cohort2
2nd cohort Between-groups comparison
1st and 2nd cohort 2009-201132006-2008 2009-2011 2009-2011
Mean (SD) Mean (SD) Estimate (95% conf. int.) p Mean (SD) Estimate (95% conf. int.) p
Diabetes
Prevalence 0.040 (0.014) 0.050 (0.013) 0.010 (0.006 - 0.015) 0.000 0.051 (0.018) -0.001 (-0.006 - 0.005) 0.79
Outcome measures
HbA1c < target 60.8 (15.9) 63.6 (11.4) 2.6 (-2.6 - 7.9) 0.32 63.6 (11.0) -0.02 (-4.0 - 3.9) 0.99
Blood pressure < target4 56.6 (16.7) 52.1 (17.0) -5.4 (-11.4 - 0.7) 0.08 50.8 (16.7) 0.9 (-4.9 - 6.7) 0.76
Total cholesterol < target4 50.4 (15.0) 45.2 (20.1) -5.4 (-12.4 - 1.5) 0.12 36.3 (20.7) 8.8 (1.5 - 16.1) 0.02
Process measures
Mean process score 79.2 (10.0) 81.6 (12.7) 2.3 (-1.5 - 6.1) 0.23 79.5 (12.7) 1.8 (-2.5 - 6.2) 0.41
HbA1c measurement 90.4 (10.2) 92.5 (7.3) 2.1 (-1.1 - 5.4) 0.20 92.4 (6.7) -0.03 (-2.5 - 2.4) 0.98
BP5 measurement 93.7 (7.0) 91.9 (13.3) -1.7 (-5.0 - 1.7) 0.32 92.4 (8.9) -0.7 (-4.7 - 3.3) 0.74
Cholesterol measurement 81.3 (14.4) 86.1 (12.4) 4.8 (0.2 - 9.4) 0.04 86.6 (9.4) -0.6 (-4.4 - 3.2) 0.74
Creatinine clearance 82.1 (13.1) 85.3 (17.0) 3.4 (-1.2 - 7.9) 0.14 83.6 (17.3) 1.2 (-4.8 - 7.2) 0.69
Retinal examination 70.6 (16.4) 66.4 (24.4) -4.5 (-12.0 - 3.1) 0.24 62.3 (26.6) 3.9 (-4.9 - 12.7) 0.39
Feet examination 57.3 (22.7) 67.1 (26.4) 9.7(0.9 - 18.5) 0.03 59.7 (27.1) 7.2 (-2.1 - 16.5) 0.13
Prescription of lipid lowering medication 60.5 (16.4) 69.9 (22.6) 9.5 (2.5 - 16.4) 0.009 68.4 (13.1) 1.1 (-5.1 - 7.4) 0.72
Chronic obstructive pulmonary disease (COPD)
Prevalence 0.017 (0.009) 0.022 (0.008) 0.005 (0.003 - 0.008) 0.000 0.023 (0.010) -0.001 (-0.004 - 0.003) 0.65
Outcome measure
Patients that smoke 36.6 (22.9) 31.8 (16.1) -4.9 (-11.5 - 1.8) 0.15 32.2 (20.7) -0.4 (-6.9 - 6.2) 0.92
Process measures
Mean process score 58.5 (17.8) 67.2 (22.1) 8.3 (1.8 - 14.8) 0.01 61.6 (24.9) 5.5 (-2.8 - 13.8) 0.19
Smoke status known 76.0 (21.4) 75.4 (23.2) -1.3 (-8.1 - 5.6) 0.71 69.4 (27.0) 6.1 (-2.8 - 15.0) 0.18
Spirometry 41.2 (23.5) 58.8 (28.7) 17.0 (8.0 - 26.0) 0.000 53.8 (28.5) 4.7 (-5.5 - 14.8) 0.37
Stop smoking advice 47.0 (33.9) 69.8 (30.8) 21.8 (8.7 - 34.9) 0.002 65.2 (32.6) 5.1 (-10.1 - 20.2) 0.51
Cardiovascular disease (CVD)6
Outcome measures
Patients that smoke - 12.6 (8.5) - - 10.5 (7.8) 1.9 (-1.1 - 4.9) 0.20
Blood pressure < target4 - 41.8 (15.5) - - 35.7 (14.7) 6.3 (0.6 - 11.9) 0.03
Process measures
Mean process score - 61.3 (20.3) - - 54.5 (21.6) 6.5 (-1.2 - 14.1) 0.10
Smoke status known - 51.7 (26.6) - - 39.8 (25.5) 11.3 (1.9 - 20.8) 0.02
BP5 measurement - 70.8 (17.9) - - 69.3 (21.3) 1.6 (-5.6 - 8.9) 0.66
Stop smoking advice - 66.7 (34.2) - - 51.1 (34.0) 13.2 (-4.6 - 30.9) 0.14
Glucose measurement - 77.5 (17.6) - - 64.3 (24.3) 12.0 (1.9 - 22.0) 0.02
Prescription of anticoagulants - 78.8 (15.0) - - 76.5 (20.4) 1.6 (-5.1 - 8.3) 0.64
1Except for prevalence values, all values in this table report the percentage of patients treated according to the guidelines/for which the indicator was met
(deviations, estimates and 95% confidence intervals are also reported in number of percentage points). 2Results are based on multilevel regression analyses,
accounting for repeated measures per practice and correcting for practice size, practice type and practice location. 3Results are based on regression analyses,
correcting for practice size, practice type and practice location. 4In prevailing guidelines, target levels on blood pressure and cholesterol were tightened over time.
This may partly account for a decrease in these scores regarding diabetes. 5BP = blood pressure. 6The inclusion criteria for patients with risk for cardiovascular
disease changed towards the inclusion of patients with known cardiovascular disease only, which made a within-group comparison of the first cohort
not justifiable.
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during our research period. Starting in 2007, bundled
payment was implemented broadly for diabetes and to a
more limited extent for COPD; implementation of bun-
dled payment for CVD just started at the end of our re-
search period (2011). Although a large part of the
practices may currently participate in bundled payment
schemes [15], during our study period, most schemes
were only just set up. Bundled payment offers audit and
feedback and funds for support/education etcetera, but
no other interventions to achieve quality improvement.
The Dutch accreditation program is one example of an
intervention that can complement further implementa-
tion through the development of improvement plans
and continuous support. There are clear similarities be-
tween participation in bundled payment and the ac-
creditation process as an audit and feedback system.
Both require data collection and offer feedback; mea-
sures used on diabetes, COPD and CVD are almost
identical. In fact, practices that participate in both initia-
tives often collect data only once and use the data for
both purposes. This might explain why little added value
of the accreditation program was detected for diabetes
and COPD, two conditions for which many practices
also participate in a bundled payment initiative. It could
also account for the effect of accreditation on CVD,
since implementation of bundled payment for this con-
dition only just started during our research period.
Strenghts and limitations
Our study design implied a risk of confounding, because
of the absence of random allocation. The second cohort
was selected out of a possible 802 practices of all 4917
Dutch practices (16.3%) [29]. At the end of our study
period, more than half of all Dutch general practitioners
(over 4600) worked in a practice that took part in the ac-
creditation program and more than 40% of all practices
were accredited. It is likely that a substantial part of
these practices also participated in bundled payment for
diabetes and COPD; the lack of exact information on
this limited this study. In our models, we accounted for
practice type, size and location. However, there may have
been an underrepresentation of practices with a less than
average interest in quality improvement, especially in the
first cohort, since participation in the program was vol-
untary. Both the argument of confounding and of the
representation of the study population reflect on the
possibility that the effects could be more present in the
whole population of general practices.
The increase in diabetes and COPD prevalence be-
tween 2006 and 2011 may indicate that practices have
improved their registration. On the other hand it can
also be a result of efforts to screen the population for
undiagnosed patients. Process indicator scores might de-
crease when registration is better, since there is an
association between performing a measurement and regis-
tering it. This can cause a bias, which may differ when
registration improves. Outcome scores might increase
after active screening of the population, due to the inclu-
sion of patients with a mild form of diabetes or COPD.
Conclusions
General practices improved the quality of provided
healthcare for patients with the targeted chronic dis-
eases. Nevertheless, only a few improvements could be
attributed to the accreditation program, which may be
caused by the fact that other programs address quality of
chronic illness care at the same time. Expectations of the
effects of accreditation were high among participants
and stakeholders, but the results of this evaluation do
not support these fully. Continuous monitoring may
have been beneficial for practices in order to maintain a
high level of quality in some areas and improve further
in others. After the study was completed, adaptations to
the program were made, which reduced the burden of
work and may improve the effectiveness. For instance,
these could stimulate practices to not focus solely on the
measured items [30].
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